high-grade salivary gland mucoepidermoid carcinoma
Showing 1 - 25 of >10,000
High-grade Salivary Gland Carcinoma Trial in Seoul (nivolumab, docetaxel, cisplatin Group)
Recruiting
- High-grade Salivary Gland Carcinoma
- nivolumab, docetaxel, cisplatin Group
-
Seoul, Korea, Republic ofDepartment of Medicine, Samsung Medical Center, Sungkyunkwan Uni
Feb 3, 2023
Prostatic Tumors, Castration-Resistant, Tumors by Histologic Type, Tumors, Prostate Trial in United States (P-PSMA-101 CAR-T
Active, not recruiting
- Prostatic Neoplasms, Castration-Resistant
- +16 more
- P-PSMA-101 CAR-T cells
- Rimiducid
-
Duarte, California
- +9 more
Nov 15, 2022
Head Neck Cancer Trial in Canada, Saudi Arabia, United States (cisplatin, 3-dimensional conformal radiation therapy,
Active, not recruiting
- Head and Neck Cancer
- cisplatin
- +2 more
-
Birmingham, Alabama
- +267 more
Apr 6, 2022
Metastatic Breast Carcinoma, Locally Advanced Breast Cancer, Cancer of Pancreas Trial in Brussels (68GaNOTA-Anti-HER2 VHH1)
Recruiting
- Metastatic Breast Carcinoma
- +13 more
- 68GaNOTA-Anti-HER2 VHH1
-
Brussels, Brussel, BelgiumUz Brussel
Dec 17, 2021
Salivary Gland Cancer Trial in Seoul (docetaxel plus Cisplatin)
Active, not recruiting
- Salivary Gland Cancer
- docetaxel plus Cisplatin
-
Seoul, Gangnamgu, Korea, Republic ofSamsung Medical Center
Aug 16, 2021
Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)
Recruiting
- Bone Sarcoma
- +15 more
- Aldesleukin
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022
PSMA-PET Imaging of Salivary Gland Tumours and Other Rare
Recruiting
- Salivary Gland Tumor
- Rare Malignant Neoplasm
- 68-Ga PSMA PET scan
-
Singapore, SingaporeNational Cancer Centre Singapore
Oct 11, 2022
Salivary Gland Carcinoma Trial in United States (Goserelin Acetate, Pembrolizumab)
Recruiting
- Salivary Gland Carcinoma
- Goserelin Acetate
- Pembrolizumab
-
Chicago, Illinois
- +6 more
Sep 22, 2022
Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage III Major Salivary Gland Cancer AJCC v8 Trial
Recruiting
- Metastatic Salivary Gland Carcinoma
- +4 more
- Docetaxel
- +3 more
-
New York, New YorkMemorial Sloane Kettering Cancer Center
Jan 11, 2023
Xerostomia Following Radiotherapy Trial in Ljubljana (allogeneic mesenchymal stromal stem cells)
Not yet recruiting
- Xerostomia Following Radiotherapy
- allogeneic mesenchymal stromal stem cells
-
Ljubljana, Slovenia
- +3 more
Aug 22, 2023
Salivary Gland Cancer, Salivary Duct Carcinoma, Adenoid Cystic Carcinoma Trial in Nijmegen (Lutetium-177-PSMA-I&T)
Recruiting
- Salivary Gland Cancer
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Oct 27, 2022
Salivary Gland Cancer Trial (vedicitumomab (Edisil, RC48), vedicitumomab in combination with pyrrolizidine, RC48 in combination
Not yet recruiting
- Salivary Gland Cancer
- vedicitumomab (Edisil, RC48)
- +3 more
- (no location specified)
Jun 9, 2023
Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen
Recruiting
- Acinar Cell Carcinoma
- +93 more
- Biospecimen Collection
- +2 more
-
Birmingham, Alabama
- +998 more
Aug 23, 2022
Advanced Salivary Gland Carcinoma Trial in Shanghai (SHR-A1811, SHR 3680 + leuprolide, SHR-A1921)
Not yet recruiting
- Advanced Salivary Gland Carcinoma
- SHR-A1811
- +2 more
-
Shanghai, ChinaDongmei Ji
Jun 21, 2023
Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8 Trial in
Recruiting
- Metastatic Salivary Gland Carcinoma
- +5 more
- Pembrolizumab
- Pemetrexed Disodium
-
Scottsdale, Arizona
- +2 more
Mar 15, 2022
Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma, Neoadjuvant or Conversion Therapy, Precision Therapy Trial in
Recruiting
- Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma
- +2 more
- Vedolizumab
- +5 more
-
Beijing, Beijing, China
- +1 more
Nov 21, 2023
Adenoid Cystic Carcinoma, Adenoid Cystic Carcinoma of the Salivary Gland Trial in Boston (Implantable Microdevice (IMD))
Not yet recruiting
- Adenoid Cystic Carcinoma
- Adenoid Cystic Carcinoma of the Salivary Gland
- Implantable Microdevice (IMD)
-
Boston, Massachusetts
- +1 more
Sep 22, 2022
Immune Biomarker Study for Salivary Gland Carcinoma
Not yet recruiting
- Salivary Gland Tumor
- Benign Salivary Gland Tumor
- Sampling
-
Erlangen, Bavaria, Germany
- +1 more
Sep 21, 2023
Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)
Recruiting
- Malignant Salivary Gland Cancer
- Salivary Gland Cancer
-
Tampa, Florida
- +2 more
Feb 10, 2022
Salivary Gland Tumors Trial in Shanghai (Pyrotinib, Bicalutamide, Leuprorelin)
Recruiting
- Salivary Gland Neoplasms
- Pyrotinib
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital Affiliated to Shanghai Jiao Ton
Oct 8, 2021
Gland, Salivary Gland Cancers Trial in Houston (Sacituzumab Govitecan)
Not yet recruiting
- Gland
- Salivary Gland Cancers
- Sacituzumab Govitecan
-
Houston, TexasM D Anderson Cancer Center
May 22, 2023
Warthin's Tumor of Parotid Gland Trial in Assiut (Ultrasound-Guided Ethanol Sclerotherapy (UGES))
Recruiting
- Warthin's Tumor of Parotid Gland
- Ultrasound-Guided Ethanol Sclerotherapy (UGES)
-
Assiut, EgyptAssiut university
Jan 23, 2022